Risk of osteoporotic fractures in new users of denosumab compared with new users of alendronate: A Danish populationbased cohort study
Main Authors: | Pedersen, AB, Heide-Jorgensen, U, Sorensen, HT, Prieto-Alhambra, D, Ehrenstein, V |
---|---|
Format: | Conference item |
Published: |
Wiley
2018
|
Similar Items
-
Comparison of risk of osteoporotic fracture in Denosumab vs Alendronate treatment within 3 years of initiation
by: Pedersen, AB, et al.
Published: (2019) -
Reduction in fracture rates with Denosumab compared to Alendronate in treatment naïve patients: a propensity-matched ‘real world’ cohort and instrumental variable analysis.
by: Khalid, S, et al.
Published: (2017) -
Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
by: Eiken, P, et al.
Published: (2017) -
Use of Thiazolidinediones and Risk of Osteoporotic Fracture: The Danish National Databases
by: Bazelier, M, et al.
Published: (2011) -
Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
by: Prieto Alhambra, D, et al.
Published: (2016)